These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 26701856)
1. Fast clearance of lipid droplets through MAP1S-activated autophagy suppresses clear cell renal cell carcinomas and promotes patient survival. Xu G; Jiang Y; Xiao Y; Liu XD; Yue F; Li W; Li X; He Y; Jiang X; Huang H; Chen Q; Jonasch E; Liu L Oncotarget; 2016 Feb; 7(5):6255-65. PubMed ID: 26701856 [TBL] [Abstract][Full Text] [Related]
2. Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis. Xu G; Yue F; Huang H; He Y; Li X; Zhao H; Su Z; Jiang X; Li W; Zou J; Chen Q; Liu L Aging (Albany NY); 2016 May; 8(5):977-85. PubMed ID: 27236336 [TBL] [Abstract][Full Text] [Related]
3. Transforming Growth Factor TGFβ Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas. Song K; Hu W; Yue F; Zou J; Li W; Chen Q; Yao Q; Sun W; Liu L PLoS One; 2015; 10(11):e0143150. PubMed ID: 26571030 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial E3 ubiquitin ligase 1 promotes autophagy flux to suppress the development of clear cell renal cell carcinomas. Yuan Y; Li X; Xu Y; Zhao H; Su Z; Lai D; Yang W; Chen S; He Y; Li X; Liu L; Xu G Cancer Sci; 2019 Nov; 110(11):3533-3542. PubMed ID: 31489722 [TBL] [Abstract][Full Text] [Related]
5. Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients. Jiang X; Zhong W; Huang H; He H; Jiang F; Chen Y; Yue F; Zou J; Li X; He Y; You P; Yang W; Lai Y; Wang F; Liu L Mol Carcinog; 2015 Oct; 54(10):1194-204. PubMed ID: 25043940 [TBL] [Abstract][Full Text] [Related]
6. Defects in MAP1S-mediated autophagy cause reduction in mouse lifespans especially when fibronectin is overexpressed. Li W; Zou J; Yue F; Song K; Chen Q; McKeehan WL; Wang F; Xu G; Huang H; Yi J; Liu L Aging Cell; 2016 Apr; 15(2):370-9. PubMed ID: 26750654 [TBL] [Abstract][Full Text] [Related]
7. MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma. Cai Z; Luo W; Wang H; Zhu R; Yuan Y; Zhan X; Xie M; Zhuang H; Chen H; Xu Y; Li X; Liu L; Xu G Cancer Sci; 2024 Jun; 115(6):1791-1807. PubMed ID: 38480904 [TBL] [Abstract][Full Text] [Related]
8. Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin. Yue F; Li W; Zou J; Chen Q; Xu G; Huang H; Xu Z; Zhang S; Gallinari P; Wang F; McKeehan WL; Liu L Aging (Albany NY); 2015 Oct; 7(10):839-53. PubMed ID: 26540094 [TBL] [Abstract][Full Text] [Related]
9. MAP1S enhances autophagy to suppress tumorigenesis. Liu L; McKeehan WL; Wang F; Xie R Autophagy; 2012 Feb; 8(2):278-80. PubMed ID: 22301994 [TBL] [Abstract][Full Text] [Related]
10. MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes. Dutta P; Haller E; Sharp A; Nanjundan M BMC Cancer; 2016 Jan; 16():33. PubMed ID: 26794413 [TBL] [Abstract][Full Text] [Related]
11. Microtubule-associated protein 1S (MAP1S) bridges autophagic components with microtubules and mitochondria to affect autophagosomal biogenesis and degradation. Xie R; Nguyen S; McKeehan K; Wang F; McKeehan WL; Liu L J Biol Chem; 2011 Mar; 286(12):10367-77. PubMed ID: 21262964 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability. Zou J; Yue F; Jiang X; Li W; Yi J; Liu L Biochem J; 2013 Sep; 454(3):447-57. PubMed ID: 23822101 [TBL] [Abstract][Full Text] [Related]
13. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424 [TBL] [Abstract][Full Text] [Related]
14. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival. Du P; Ye L; Yang Y; Jiang WG Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253 [TBL] [Abstract][Full Text] [Related]
15. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
16. Spermidine suppresses the activation of hepatic stellate cells to cure liver fibrosis through autophagy activator MAP1S. Shi B; Wang W; Ye M; Liang M; Yu Z; Zhang Y; Liu Z; Liang X; Ao J; Xu F; Xu G; Jiang X; Zhou X; Liu L Liver Int; 2023 Jun; 43(6):1307-1319. PubMed ID: 36892418 [TBL] [Abstract][Full Text] [Related]
17. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma]. Yang J; Cheng TT; Wang LN; Chen W; Li X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834 [TBL] [Abstract][Full Text] [Related]
19. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival. Rabjerg M; Oliván-Viguera A; Hansen LK; Jensen L; Sevelsted-Møller L; Walter S; Jensen BL; Marcussen N; Köhler R PLoS One; 2015; 10(4):e0122992. PubMed ID: 25848765 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression. Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]